Dermavant Sciences, a subsidiary of Roivant Sciences, is a clinical-stage biopharmaceutical company committed to fostering unprecedented change and unparalleled impact in immuno-dermatology. We’re doing this by thinking differently, pushing the boundaries of science and partnering with providers in new ways—all with one goal: transforming the lives of millions of patients with skin diseases.
“The ability to transform lives”
“A passion for helping people”
Philip M Brown, MD, JD
“Fundamentally changing the lives of patients”
David Rubenstein, MD, PhD